Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin
For centuries, plants have been exploited by mankind as sources of numerous cancer chemotherapeutic agents. Good examples of anticancer compounds of clinical significance today include the taxanes (e.g., taxol), vincristine, vinblastine, and the podophyllotoxin analogues that all trace their origin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9059/6/2/39 |
_version_ | 1819091126936666112 |
---|---|
author | Solomon Habtemariam Giovanni Lentini |
author_facet | Solomon Habtemariam Giovanni Lentini |
author_sort | Solomon Habtemariam |
collection | DOAJ |
description | For centuries, plants have been exploited by mankind as sources of numerous cancer chemotherapeutic agents. Good examples of anticancer compounds of clinical significance today include the taxanes (e.g., taxol), vincristine, vinblastine, and the podophyllotoxin analogues that all trace their origin to higher plants. While all these drugs, along with the various other available therapeutic options, brought some relief in cancer management, a real breakthrough or cure has not yet been achieved. This critical review is a reflection on the lessons learnt from decades of research on the iridoid glycoside geniposide and its aglycone, genipin, which are currently used as gold standard reference compounds in cancer studies. Their effects on tumour development (carcinogenesis), cancer cell survival, and death, with particular emphasis on their mechanisms of actions, are discussed. Particular attention is also given to mechanisms related to the dual pro-oxidant and antioxidant effects of these compounds, the mitochondrial mechanism of cancer cell killing through reactive oxygen species (ROS), including that generated through the uncoupling protein-2 (UCP-2), the inflammatory mechanism, and cell cycle regulation. The implications of various studies for the evaluation of glycosidic and aglycone forms of natural products in vitro and in vivo through pharmacokinetic scrutiny are also addressed. |
first_indexed | 2024-12-21T22:34:46Z |
format | Article |
id | doaj.art-7b4104c3283b4da18c44519f885f12aa |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-12-21T22:34:46Z |
publishDate | 2018-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-7b4104c3283b4da18c44519f885f12aa2022-12-21T18:48:00ZengMDPI AGBiomedicines2227-90592018-03-01623910.3390/biomedicines6020039biomedicines6020039Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, GenipinSolomon Habtemariam0Giovanni Lentini1Pharmacognosy Research Laboratories, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, UKDepartment of Pharmacy-Drug Sciences, University of Studies of Bari Aldo Moro, Via E. Orabona n. 4, 70126 Bari, ItalyFor centuries, plants have been exploited by mankind as sources of numerous cancer chemotherapeutic agents. Good examples of anticancer compounds of clinical significance today include the taxanes (e.g., taxol), vincristine, vinblastine, and the podophyllotoxin analogues that all trace their origin to higher plants. While all these drugs, along with the various other available therapeutic options, brought some relief in cancer management, a real breakthrough or cure has not yet been achieved. This critical review is a reflection on the lessons learnt from decades of research on the iridoid glycoside geniposide and its aglycone, genipin, which are currently used as gold standard reference compounds in cancer studies. Their effects on tumour development (carcinogenesis), cancer cell survival, and death, with particular emphasis on their mechanisms of actions, are discussed. Particular attention is also given to mechanisms related to the dual pro-oxidant and antioxidant effects of these compounds, the mitochondrial mechanism of cancer cell killing through reactive oxygen species (ROS), including that generated through the uncoupling protein-2 (UCP-2), the inflammatory mechanism, and cell cycle regulation. The implications of various studies for the evaluation of glycosidic and aglycone forms of natural products in vitro and in vivo through pharmacokinetic scrutiny are also addressed.http://www.mdpi.com/2227-9059/6/2/39cancercarcinogenesismetastasisgenipingeniposidereactive oxygen speciesapoptosisuncoupling protein 2 |
spellingShingle | Solomon Habtemariam Giovanni Lentini Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin Biomedicines cancer carcinogenesis metastasis genipin geniposide reactive oxygen species apoptosis uncoupling protein 2 |
title | Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin |
title_full | Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin |
title_fullStr | Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin |
title_full_unstemmed | Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin |
title_short | Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin |
title_sort | plant derived anticancer agents lessons from the pharmacology of geniposide and its aglycone genipin |
topic | cancer carcinogenesis metastasis genipin geniposide reactive oxygen species apoptosis uncoupling protein 2 |
url | http://www.mdpi.com/2227-9059/6/2/39 |
work_keys_str_mv | AT solomonhabtemariam plantderivedanticanceragentslessonsfromthepharmacologyofgeniposideanditsaglyconegenipin AT giovannilentini plantderivedanticanceragentslessonsfromthepharmacologyofgeniposideanditsaglyconegenipin |